149 related articles for article (PubMed ID: 38270548)
1. Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use.
Taipale H; Solmi M; Correll CU; Tiihonen J
J Clin Psychiatry; 2024 Jan; 85(1):. PubMed ID: 38270548
[No Abstract] [Full Text] [Related]
2. Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years).
Rahman T; Sahrmann JM; Olsen MA; Nickel KB; Miller JP; Ma C; Grucza RA
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):7-16. PubMed ID: 34864772
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic agents and serum prolactin levels.
JAMA; 1976 Nov; 236(19):2175. PubMed ID: 10453
[No Abstract] [Full Text] [Related]
4. Association between long-term use of prolactin-elevating antipsychotics in women and the risk of breast cancer: What are the clinical implications?
Hope JD; Keks NA; Copolov DL
Australas Psychiatry; 2023 Apr; 31(2):205-208. PubMed ID: 36927059
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic treatment, prolactin, and breast tumorigenesis.
De Hert M; Vancampfort D; Stubbs B; Sabbe T; Wildiers H; Detraux J
Psychiatr Danub; 2016 Sep; 28(3):243-254. PubMed ID: 27658833
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Limitations of the Odds Ratio in a Case-Control Study of the Association Between Breast Cancer and Exposure to Antipsychotic Drugs.
Andrade C
J Clin Psychiatry; 2021 Nov; 82(6):. PubMed ID: 34813689
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue.
Schyve PM; Smithline F; Meltzer HY
Arch Gen Psychiatry; 1978 Nov; 35(11):1291-1301. PubMed ID: 30426
[TBL] [Abstract][Full Text] [Related]
8. Dopamine antagonists and the development of breast cancer.
Wang PS; Walker AM; Tsuang MT; Orav EJ; Glynn RJ; Levin R; Avorn J
Arch Gen Psychiatry; 2002 Dec; 59(12):1147-54. PubMed ID: 12470131
[TBL] [Abstract][Full Text] [Related]
9. Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study.
Pottegård A; Lash TL; Cronin-Fenton D; Ahern TP; Damkier P
Br J Clin Pharmacol; 2018 Sep; 84(9):2152-2161. PubMed ID: 29858518
[TBL] [Abstract][Full Text] [Related]
10. Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review.
Froes Brandao D; Strasser-Weippl K; Goss PE
Cancer; 2016 Jan; 122(2):184-8. PubMed ID: 26457577
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer in hospitalized psychiatric patients.
Goode DJ; Corbett WT; Schey HM; Suh SH; Woodie B; Morris DL; Morrisey L
Am J Psychiatry; 1981 Jun; 138(6):804-6. PubMed ID: 6113769
[TBL] [Abstract][Full Text] [Related]
12. [Prolactin, antipsychotics and breast cancer: is there a connection?].
Sabbe T; Detraux J; De Hert M
Tijdschr Psychiatr; 2016; 58(9):641-9. PubMed ID: 27639886
[TBL] [Abstract][Full Text] [Related]
13. Prolactin and breast cancer risk.
Beumont PJ
Med J Aust; 1991 Feb; 154(3):219. PubMed ID: 1671167
[No Abstract] [Full Text] [Related]
14. Prolactin and Estrogen Levels in Postmenopausal Women Receiving Aripiprazole Augmentation Treatment for Depression.
Rahman T; Patrick C; Ma C; Nicol GE; Reynolds CF; Mulsant BH; Hartz SM; Yingling M; Lenze EJ
J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):31-35. PubMed ID: 33347020
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic treatment in breast cancer patients.
Rahman T; Clevenger CV; Kaklamani V; Lauriello J; Campbell A; Malwitz K; Kirkland RS
Am J Psychiatry; 2014 Jun; 171(6):616-21. PubMed ID: 24880509
[TBL] [Abstract][Full Text] [Related]
16. Prolactin and human breast cancer.
Minton JP
Am J Surg; 1974 Nov; 128(5):628-30. PubMed ID: 4155252
[No Abstract] [Full Text] [Related]
17. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.
De Hert M; Peuskens J; Sabbe T; Mitchell AJ; Stubbs B; Neven P; Wildiers H; Detraux J
Acta Psychiatr Scand; 2016 Jan; 133(1):5-22. PubMed ID: 26114737
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic-induced hyperprolactinemia.
Bostwick JR; Guthrie SK; Ellingrod VL
Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
[TBL] [Abstract][Full Text] [Related]
19. Are dopamine antagonists a risk factor for breast cancer? An answer from Parkinson's disease.
Lalonde FM; Myslobodsky M
Breast; 2003 Aug; 12(4):280-2. PubMed ID: 14659314
[TBL] [Abstract][Full Text] [Related]
20. Adverse effects of prolactin in rodents and humans: breast and prostate cancer.
Harvey PW; Everett DJ; Springall CJ
J Psychopharmacol; 2008 Mar; 22(2 Suppl):20-7. PubMed ID: 18709700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
